SCHEMBL4551493

SCHEMBL4551493

Cc1ccc(Nc2cc(F)cc(N3CCCOCC3)c2)cc1-c1cc(C(=O)NCc2cccnc2)on1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41
MAPT P10636 1/20 0.41
MAPK14 Q16539 3/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
LMNA P02545 1/20 0.40
GFER P55789 1/20 0.40
PIK3CA P42336 1/20 0.40
DHODH Q02127 1/20 0.39
RAF1 P04049 2/20 0.39
BRAF P15056 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5603996 0.98 NAMPT (0.45) NAMPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4551494 0.90 MAPK14 (0.51) NAMPTMAPK14TP53MAPK13MAPK12
SCHEMBL4541474 0.90 RAF1 (0.42) CYP3A4CYP2C9MAPK14RAF1BRAF
SCHEMBL4551596 0.89 NAMPT (0.54) NAMPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5603999 0.88 MAPK14 (0.53) NAMPTMAPK14TP53MAPK13MAPK12
SCHEMBL5603875 0.87 NAMPT (0.41) NAMPTCYP1A2CYP3A4CYP2C9TP53
SCHEMBL4551892 0.86 RAF1 (0.44) MAPK14RAF1BRAF
SCHEMBL4410223 0.86 MAPK14 (0.47) NAMPTMAPTMAPK14TP53TSHR
SCHEMBL4551775 0.85 MAPT (0.48) MAPTMAPK14MAPK11RAF1BRAF
SCHEMBL4411272 0.85 MAPK14 (0.46) NAMPTMAPTMAPK14TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed